These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 18635284

  • 21. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
    Nakagawa M, Hara M, Sakurai K, Ozawa Y, Mizuno A, Tamaki T, Nishio M, Shibamoto Y.
    Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198
    [Abstract] [Full Text] [Related]

  • 22. The maximum standardized 18F-fluorodeoxyglucose uptake on positron emission tomography predicts lymph node metastasis and invasiveness in clinical stage IA non-small cell lung cancer.
    Maeda R, Isowa N, Onuma H, Miura H, Harada T, Touge H, Tokuyasu H, Kawasaki Y.
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):79-82. PubMed ID: 19366724
    [Abstract] [Full Text] [Related]

  • 23. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients.
    Kim YK, Lee KS, Kim BT, Choi JY, Kim H, Kwon OJ, Shim YM, Yi CA, Kim HY, Chung MJ.
    Cancer; 2007 Mar 15; 109(6):1068-77. PubMed ID: 17311309
    [Abstract] [Full Text] [Related]

  • 24. [Value of (18)F-FDG PET-CT in the preoperative N staging of non-small cell lung cancer].
    Li M, Wu N, Liang Y, Zheng R, Liu Y, Zhang WJ, Zhao P.
    Zhonghua Zhong Liu Za Zhi; 2009 Apr 15; 31(4):288-92. PubMed ID: 19615286
    [Abstract] [Full Text] [Related]

  • 25. The asphericity of the metabolic tumour volume in NSCLC: correlation with histopathology and molecular markers.
    Apostolova I, Ego K, Steffen IG, Buchert R, Wertzel H, Achenbach HJ, Riedel S, Schreiber J, Schultz M, Furth C, Derlin T, Amthauer H, Hofheinz F, Kalinski T.
    Eur J Nucl Med Mol Imaging; 2016 Dec 15; 43(13):2360-2373. PubMed ID: 27470327
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
    Fernandes AT, Mitra N, Xanthopoulos E, Evans T, Stevenson J, Langer C, Kucharczuk JC, Lin L, Rengan R.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):340-7. PubMed ID: 22104359
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Prognostic stratification of stage IIIA-N2 non-small-cell lung cancer after induction chemotherapy: a model based on the combination of morphometric-pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose positron emission tomography.
    Dooms C, Verbeken E, Stroobants S, Nackaerts K, De Leyn P, Vansteenkiste J.
    J Clin Oncol; 2008 Mar 01; 26(7):1128-34. PubMed ID: 18309948
    [Abstract] [Full Text] [Related]

  • 31. Role of FDG-PET in the assessment of survival prognosis in melanoma.
    Pleiss C, Risse JH, Biersack HJ, Bender H.
    Cancer Biother Radiopharm; 2007 Dec 01; 22(6):740-7. PubMed ID: 18158764
    [Abstract] [Full Text] [Related]

  • 32. Value of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinoma.
    Hellwig D, Graeter TP, Ukena D, Georg T, Kirsch CM, Schäfers HJ.
    J Thorac Cardiovasc Surg; 2004 Dec 01; 128(6):892-9. PubMed ID: 15573074
    [Abstract] [Full Text] [Related]

  • 33. Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index.
    Vesselle H, Salskov A, Turcotte E, Wiens L, Schmidt R, Jordan CD, Vallières E, Wood DE.
    J Thorac Oncol; 2008 Sep 01; 3(9):971-8. PubMed ID: 18758298
    [Abstract] [Full Text] [Related]

  • 34. Ratio of standardized uptake value on PET helps predict response and outcome after chemotherapy in advanced non-small cell lung cancer.
    Kaira K, Endo M, Asakura K, Tsuya A, Nakamura Y, Naito T, Murakami H, Takahashi T, Yamamoto N.
    Ann Nucl Med; 2010 Dec 01; 24(10):697-705. PubMed ID: 20824397
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.
    Al-Sarraf N, Aziz R, Gately K, Lucey J, Wilson L, McGovern E, Young V.
    Eur J Cardiothorac Surg; 2008 Jan 01; 33(1):104-9. PubMed ID: 17977738
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.